WA
Wealth Advisors of Iowa, LLC
13F filer · CIK 0001803005Reported Jul 30, 2026
Net buyer this quarter
13F portfolio value$369MU.S. long equity reported on 13F
Positions493 new · 2 closed
Net flow last quarter+$44KBuys minus sells
Top 10 positions weight6.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 30, 202649 positions | |||||
| $6.07M | 1.65% | 0.00% | -0.1% | Q1 2020 | |
| $2.85M | 0.77% | 0.00% | 0.0% | Q1 2022 | |
| $2.59M | 0.70% | Not reported | -1.2% | Q1 2020 | |
| $2.25M | 0.61% | Not reported | Not reported | Q1 2020 | |
| $2.04M | 0.55% | 0.00% | -0.7% | Q1 2020 | |
| $2.01M | 0.54% | 0.01% | 0.0% | Q1 2022 | |
| $2M | 0.54% | 0.00% | +5.5% | Q1 2020 | |
| $1.99M | 0.54% | 0.00% | -4.4% | Q4 2022 | |
| $1.79M | 0.49% | 0.00% | -0.3% | Q1 2020 | |
| $1.78M | 0.48% | Not reported | -1.1% | Q1 2020 | |
| $1.43M | 0.39% | 0.00% | -0.6% | Q2 2020 | |
| $1.3M | 0.35% | Not reported | +12.6% | Q1 2020 | |
| $1.2M | 0.33% | 0.00% | -2.9% | Q3 2022 | |
| $1.16M | 0.31% | 0.00% | 0.0% | Q1 2020 | |
| $1.12M | 0.30% | 0.00% | Not reported | Q3 2025 | |
| $1.12M | 0.30% | 0.00% | -1.4% | Q2 2021 | |
| $946K | 0.26% | 0.00% | -3.0% | Q4 2023 | |
| $940K | 0.25% | 0.00% | +1.1% | Q1 2020 | |
| $900K | 0.24% | 0.00% | Not reported | Q4 2023 | |
| $859K | 0.23% | Not reported | -1.6% | Q1 2020 | |
| PBPMBSPuramed Bioscience Inc. | $815K | 0.22% | 0.01% | -2.0% | Q1 2026 |
| $737K | 0.20% | 0.00% | 0.0% | Q4 2023 | |
| $626K | 0.17% | 0.00% | Not reported | Q2 2021 | |
| $563K | 0.15% | 0.00% | +0.2% | Q1 2025 | |
| $529K | 0.14% | 0.00% | Not reported | Q3 2024 | |
| $488K | 0.13% | 0.00% | Not reported | Q3 2022 | |
| $447K | 0.12% | 0.00% | Not reported | Q1 2020 | |
| $422K | 0.11% | 0.00% | -0.4% | Q1 2025 | |
| $422K | 0.11% | 0.00% | -6.8% | Q1 2023 | |
| $409K | 0.11% | 0.00% | +0.6% | Q2 2021 | |
| $394K | 0.11% | 0.00% | -0.4% | Q2 2025 | |
| $375K | 0.10% | 0.00% | +0.2% | Q1 2020 | |
| $333K | 0.09% | 0.00% | +6.8% | Q4 2021 | |
| $319K | 0.09% | 0.00% | -13.9% | Q4 2024 | |
| $318K | 0.09% | 0.00% | -0.6% | Q4 2021 | |
| $317K | 0.09% | 0.00% | +3.6% | Q2 2021 | |
| $304K | 0.08% | 0.00% | -5.6% | Q4 2021 | |
| $282K | 0.08% | 0.00% | Not reported | Q1 2020 | |
| $273K | 0.07% | 0.00% | +4.0% | Q4 2021 | |
| $258K | 0.07% | 0.00% | -1.7% | Q4 2022 | |
| $239K | 0.06% | 0.00% | +2.6% | Q1 2022 | |
| $222K | 0.06% | 0.00% | Not reported | Q4 2021 | |
| $219K | 0.06% | 0.00% | -37.5% | Q1 2025 | |
| $218K | 0.06% | 0.00% | Not reported | Q4 2021 | |
| $211K | 0.06% | 0.00% | +0.1% | Q1 2026 | |
| $210K | 0.06% | 0.00% | +0.9% | Q1 2020 | |
| $203K | 0.05% | 0.00% | -13.2% | Q1 2020 | |
| $202K | 0.05% | 0.00% | -8.7% | Q3 2022 | |
| $200K | 0.05% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 13, 202648 positions | |||||
| $5.33M | 1.65% | 0.00% | -4.7% | Q1 2020 | |
| $2.53M | 0.78% | 0.00% | +123.3% | Q1 2022 | |
| $2.15M | 0.67% | Not reported | Not reported | Q1 2020 | |
| $2.13M | 0.66% | Not reported | +0.6% | Q1 2020 | |
| $1.91M | 0.59% | 0.00% | +2.1% | Q1 2020 | |
| $1.88M | 0.58% | 0.00% | -9.3% | Q1 2020 | |
| $1.84M | 0.57% | 0.01% | +12.5% | Q1 2022 | |
| $1.81M | 0.56% | 0.00% | -1.8% | Q4 2022 | |
| $1.79M | 0.55% | 0.00% | -3.2% | Q1 2020 | |
| $1.73M | 0.53% | Not reported | -1.8% | Q1 2020 | |
| $1.68M | 0.52% | 0.00% | +24.6% | Q2 2020 | |
| $1.04M | 0.32% | 0.00% | +1.4% | Q1 2020 | |
| $951K | 0.29% | 0.00% | +1.0% | Q3 2022 | |
| $912K | 0.28% | 0.00% | +1.5% | Q2 2021 | |
| $902K | 0.28% | Not reported | +14.7% | Q1 2020 | |
| $886K | 0.27% | Not reported | +13.8% | Q1 2020 | |
| PBPMBSPuramed Bioscience Inc. | $835K | 0.26% | 0.01% | New | Q1 2026 |
| $819K | 0.25% | 0.00% | +7.0% | Q1 2020 | |
| $747K | 0.23% | 0.00% | +0.1% | Q3 2025 | |
| $693K | 0.21% | 0.00% | Not reported | Q4 2023 | |
| $586K | 0.18% | 0.00% | +0.2% | Q1 2025 | |
| $553K | 0.17% | 0.00% | Not reported | Q2 2021 | |
| $539K | 0.17% | 0.00% | -1.1% | Q1 2023 | |
| $505K | 0.16% | 0.00% | +8.6% | Q2 2025 | |
| $458K | 0.14% | 0.00% | +0.4% | Q3 2022 | |
| $434K | 0.13% | 0.00% | +3.5% | Q3 2024 | |
| $431K | 0.13% | 0.00% | +0.5% | Q1 2025 | |
| $431K | 0.13% | 0.00% | +7.6% | Q1 2020 | |
| $426K | 0.13% | 0.00% | Not reported | Q4 2023 | |
| $385K | 0.12% | 0.00% | -1.2% | Q1 2020 | |
| $380K | 0.12% | 0.00% | +11.8% | Q2 2021 | |
| $351K | 0.11% | 0.00% | +1.8% | Q4 2021 | |
| $351K | 0.11% | 0.00% | +2.1% | Q2 2021 | |
| $341K | 0.11% | 0.00% | +6.3% | Q4 2023 | |
| $327K | 0.10% | 0.00% | +2.2% | Q4 2024 | |
| $321K | 0.10% | 0.00% | +18.0% | Q1 2025 | |
| $318K | 0.10% | 0.00% | +0.1% | Q4 2021 | |
| $300K | 0.09% | 0.00% | +0.3% | Q4 2021 | |
| $292K | 0.09% | 0.00% | +1.7% | Q4 2021 | |
| $291K | 0.09% | 0.00% | +1.6% | Q1 2022 | |
| $277K | 0.09% | 0.00% | Not reported | Q1 2020 | |
| $254K | 0.08% | 0.00% | +0.2% | Q3 2022 | |
| $248K | 0.08% | 0.00% | -0.3% | Q1 2020 | |
| $245K | 0.08% | 0.00% | +4.1% | Q4 2022 | |
| $219K | 0.07% | 0.00% | Not reported | Q1 2020 | |
| $211K | 0.07% | 0.00% | Not reported | Q2 2025 | |
| $206K | 0.06% | 0.00% | Not reported | Q4 2020 | |
| $203K | 0.06% | 0.00% | New | Q1 2026 | |
| Q4 2025Reported Feb 5, 202649 positions | |||||
| $6M | 1.97% | 0.00% | +3.4% | Q1 2020 | |
| $2.71M | 0.89% | 0.00% | +13.6% | Q1 2020 | |
| $2.31M | 0.76% | Not reported | -4.7% | Q1 2020 | |
| $2.26M | 0.74% | Not reported | Not reported | Q1 2020 | |
| $2.05M | 0.67% | 0.00% | -5.3% | Q1 2020 | |
| $1.97M | 0.65% | 0.00% | -5.0% | Q4 2022 | |
| $1.84M | 0.61% | Not reported | -3.3% | Q1 2020 | |
| $1.62M | 0.53% | 0.00% | Not reported | Q1 2020 | |
| $1.24M | 0.41% | 0.01% | +1.9% | Q1 2022 | |
| $1.24M | 0.41% | 0.00% | +24.9% | Q2 2020 | |
| $1.13M | 0.37% | 0.00% | +10.2% | Q1 2020 | |
| $1.1M | 0.36% | 0.00% | Not reported | Q3 2022 | |
| $978K | 0.32% | 0.00% | -12.0% | Q2 2021 | |
| $938K | 0.31% | 0.00% | +41.4% | Q1 2022 | |
| $898K | 0.30% | Not reported | -0.5% | Q1 2020 | |
| $888K | 0.29% | 0.00% | -3.6% | Q1 2020 | |
| $836K | 0.27% | Not reported | +62.1% | Q1 2020 | |
| $774K | 0.25% | 0.00% | -0.2% | Q1 2023 | |
| $628K | 0.21% | 0.00% | 0.0% | Q4 2023 | |
| $625K | 0.21% | 0.00% | +0.2% | Q1 2025 | |
| $603K | 0.20% | 0.00% | +125.0% | Q3 2025 | |
| $524K | 0.17% | 0.00% | +3.7% | Q2 2021 | |
| $483K | 0.16% | 0.00% | -2.0% | Q3 2022 | |
| $469K | 0.15% | 0.00% | -28.4% | Q3 2024 | |
| $439K | 0.14% | 0.00% | Not reported | Q2 2025 | |
| $420K | 0.14% | 0.00% | +0.5% | Q2 2021 | |
| $408K | 0.13% | 0.00% | +24.1% | Q1 2025 | |
| $399K | 0.13% | 0.00% | -5.9% | Q1 2020 | |
| $387K | 0.13% | 0.00% | -15.2% | Q4 2024 | |
| $369K | 0.12% | 0.04% | -37.7% | Q3 2024 | |
| $339K | 0.11% | 0.00% | +34.6% | Q1 2020 | |
| $338K | 0.11% | 0.00% | Not reported | Q4 2023 | |
| $330K | 0.11% | 0.00% | 0.0% | Q1 2020 | |
| $320K | 0.11% | 0.00% | Not reported | Q4 2023 | |
| $315K | 0.10% | 0.00% | +4.1% | Q4 2021 | |
| $309K | 0.10% | 0.00% | Not reported | Q4 2021 | |
| $277K | 0.09% | 0.00% | +4.5% | Q4 2021 | |
| $264K | 0.09% | 0.00% | -4.1% | Q1 2025 | |
| $251K | 0.08% | 0.00% | Not reported | Q4 2021 | |
| $250K | 0.08% | 0.00% | -3.9% | Q3 2022 | |
| $241K | 0.08% | 0.00% | -12.0% | Q2 2021 | |
| $233K | 0.08% | 0.00% | -44.4% | Q1 2020 | |
| $216K | 0.07% | 0.00% | +0.2% | Q4 2022 | |
| $211K | 0.07% | 0.00% | Not reported | Q1 2022 | |
| $208K | 0.07% | 0.00% | Not reported | Q2 2025 | |
| $207K | 0.07% | 0.00% | -1.4% | Q3 2024 | |
| $205K | 0.07% | 0.00% | -12.8% | Q2 2025 | |
| $67.8K | 0.02% | 0.02% | Not reported | Q3 2025 | |
| $16.4K | 0.01% | 6.63% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202549 positions | |||||
| $5.43M | 1.85% | 0.00% | +1.0% | Q1 2020 | |
| $2.55M | 0.87% | 0.00% | +4.7% | Q1 2020 | |
| $2.26M | 0.77% | Not reported | Not reported | Q1 2020 | |
| $2.08M | 0.71% | 0.00% | +1.1% | Q4 2022 | |
| $2.06M | 0.70% | 0.00% | +4.4% | Q1 2020 | |
| $1.91M | 0.65% | Not reported | +5.2% | Q1 2020 | |
| $1.89M | 0.64% | Not reported | +5.6% | Q1 2020 | |
| $1.74M | 0.59% | 0.00% | -7.4% | Q1 2020 | |
| $1.25M | 0.42% | 0.01% | Not reported | Q1 2022 | |
| $1M | 0.34% | Not reported | +0.5% | Q1 2020 | |
| $1M | 0.34% | 0.00% | -0.8% | Q1 2020 | |
| $897K | 0.31% | 0.00% | +2.4% | Q1 2020 | |
| $890K | 0.30% | 0.00% | Not reported | Q2 2020 | |
| $864K | 0.29% | 0.00% | +9.5% | Q2 2021 | |
| $781K | 0.27% | 0.00% | -1.4% | Q3 2022 | |
| $694K | 0.24% | 0.00% | -3.7% | Q1 2023 | |
| $657K | 0.22% | 0.00% | +0.2% | Q1 2025 | |
| $652K | 0.22% | 0.00% | Not reported | Q1 2022 | |
| $651K | 0.22% | 0.00% | 0.0% | Q4 2023 | |
| $624K | 0.21% | 0.00% | +22.0% | Q3 2024 | |
| $595K | 0.20% | 0.07% | -80.8% | Q3 2024 | |
| $538K | 0.18% | 0.00% | +2.0% | Q3 2022 | |
| $504K | 0.17% | Not reported | Not reported | Q1 2020 | |
| $451K | 0.15% | 0.00% | +20.7% | Q4 2024 | |
| $428K | 0.15% | 0.00% | +6.3% | Q1 2020 | |
| $424K | 0.14% | 0.00% | +0.6% | Q2 2021 | |
| $422K | 0.14% | 0.00% | 0.0% | Q1 2020 | |
| $398K | 0.14% | 0.00% | +0.6% | Q2 2021 | |
| $324K | 0.11% | 0.00% | +5.7% | Q4 2021 | |
| $322K | 0.11% | 0.00% | 0.0% | Q1 2020 | |
| $301K | 0.10% | 0.00% | +14.6% | Q2 2025 | |
| $300K | 0.10% | 0.00% | +10.2% | Q1 2025 | |
| $300K | 0.10% | 0.00% | Not reported | Q2 2025 | |
| $289K | 0.10% | 0.00% | Not reported | Q2 2025 | |
| $286K | 0.10% | 0.00% | +0.2% | Q4 2021 | |
| $278K | 0.09% | 0.00% | +4.8% | Q1 2025 | |
| $259K | 0.09% | 0.00% | +3.8% | Q4 2021 | |
| $258K | 0.09% | 0.00% | +4.2% | Q3 2022 | |
| $257K | 0.09% | 0.00% | +14.4% | Q2 2021 | |
| $255K | 0.09% | 0.00% | Not reported | Q4 2023 | |
| $255K | 0.09% | 0.00% | Not reported | Q4 2023 | |
| $225K | 0.08% | 0.00% | Not reported | Q1 2020 | |
| $223K | 0.08% | 0.00% | New | Q3 2025 | |
| $222K | 0.08% | 0.00% | +1.4% | Q3 2024 | |
| $215K | 0.07% | 0.00% | Not reported | Q1 2022 | |
| $208K | 0.07% | 0.00% | Not reported | Q1 2020 | |
| $205K | 0.07% | 0.00% | +0.1% | Q4 2022 | |
| $204K | 0.07% | 0.00% | Not reported | Q4 2020 | |
| $58.1K | 0.02% | 0.02% | New | Q3 2025 | |
Premium opens every quarter this fund has filed